Bennett M
St. Gemma's Hospice, Harrogate Road, LS17 6QD, Leeds, UK.
Pain. 2001 May;92(1-2):147-57. doi: 10.1016/s0304-3959(00)00482-6.
This study describes the development and validation of a novel tool for identifying patients in whom neuropathic mechanisms dominate their pain experience. The Leeds assessment of neuropathic symptoms and signs (LANSS) Pain Scale is based on analysis of sensory description and bedside examination of sensory dysfunction, and provides immediate information in clinical settings. It was developed in two populations of chronic pain patients. In the first (n = 60), the use of sensory descriptors and questions were compared in patients with nociceptive and neuropathic pain, combined with an assessment of sensory function. This data was used to derive a seven item pain scale, consisting of grouped sensory description and sensory examination with a simple scoring system. The LANSS Pain Scale was validated in a second group of patients (n = 40) by assessing discriminant ability, internal consistency and agreement by independent raters. Clinical and research applications of the LANSS Pain Scale are discussed.
本研究描述了一种用于识别以神经病理性机制为主导疼痛体验的患者的新型工具的开发与验证过程。利兹神经病理性症状和体征评估(LANSS)疼痛量表基于对感觉描述的分析和感觉功能障碍的床边检查,并能在临床环境中提供即时信息。它是在两组慢性疼痛患者中开发的。在第一组(n = 60)中,对伤害性疼痛和神经病理性疼痛患者的感觉描述词使用情况及问题进行了比较,并结合了感觉功能评估。这些数据被用于推导一个由分组感觉描述和带有简单评分系统的感觉检查组成的七项疼痛量表。通过评估判别能力、内部一致性以及独立评估者之间的一致性,在第二组患者(n = 40)中对LANSS疼痛量表进行了验证。文中还讨论了LANSS疼痛量表的临床和研究应用。